Pasteur 2030 Strategy
The Pasteur 2030 stratgic vision propels the Institut Pasteur into the future by addressing the most critical health challenges of our time. Focused on innovation, multidisciplinary research and global collaboration, Pasteur 2030 aims to strengthen our scientific leadership while enhancing public health impact.
Pasteur 2030
Strengthening it's role as the world's leading institute in research on living organisms, against infectious disease and for population health, the Institut Pasteur has developed an ambitious strategic plan for 2030 to meet the major scientific and health challenges of the coming years.
​
Under the leadership of Professor Yasmine Belkaid, Director General, and in coordination with all its collaborators, the Pasteur 2030 strategy seeks to advance our understanding of diseases, find solutions to combat them and share knowledge while defending the values of science.
​
Faced with the many risks to human health, such as infectious diseases, antibiotic resistance, aging, climate change, chronic inflammatory diseases, cancers which increasingly affect young people, and neurodegenerative diseases, the Institut Pasteur wishes to strengthen its role as the world's leading research organisation in understanding and combating these diseases by 2030.
Four Focus Areas
The four main focus areas of the Pasteur 2030 strategy are:
Pillar 1: Environmental Transitions and Health
Adapting to a Changing World
The health impacts of climate change and environmental degradation are becoming increasingly apparent. Rising temperatures, habitat disruption, and changing ecosystems create new opportunities for pathogens to thrive, leading to the emergence and re-emergence of infectious diseases. The Institut Pasteur is uniquely positioned to address these challenges through its multidisciplinary approach.
Key Focus Areas
VECTOR-BORNE DISEASES
Researching mosquito- and tick-borne illnesses such as malaria, dengue, Zika, and Lyme disease, with the aim of predicting outbreaks and developing effective interventions.
EMERGING PATHOGENS
Studying pathogens that arise due to environmental shifts, including their modes of transmission and potential for pandemics.
ENVIRONMENTAL MONITORING
Utilizing cutting-edge technologies, including satellite data and artificial intelligence, to map and predict disease hotspots linked to environmental changes.
ONE HEALTH APPROACH
Integrating the study of human, animal, and environmental health to create holistic prevention and treatment strategies.
Innovations in Progress
Development of biosensors to detect pathogen presence in ecosystems.
Creation of predictive models for climate-sensitive diseases.
Collaborative initiatives with the Pasteur Network to strengthen surveillance in high-risk regions
Pasteur-UK Projects
Tracking and Treating Malaria
Tackling Neglected Tropical Diseases
Pillar 2: Infectious Disease Threats
Strengthening Defenses Against Persistent and Emerging Threats
The world remains vulnerable to infectious diseases, from long-standing challenges like tuberculosis to emerging threats such as SARS-CoV-2. The Institut Pasteur is leveraging its historical leadership in microbiology and infectious diseases to combat these risks and address the growing challenge of antimicrobial resistance (AMR).
Key Focus Areas
ANTIMICROBIAL RESISTANCE
Tackling the 'silent pandemic' of AMR through new drug discovery, stewardship programs, and global surveillance initiatives
INNOVATIVE VACCINES
Advancing vaccine development for known and emerging pathogens, such as COVID-19 variants, Ebola, and influenza.
RAPID DIAGNOSTICS
Developing fast, affordable diagnostic tools to identify pathogens and AMR strains.
GLOBAL PREPAREDNESS
Stengthening systems to detect and respond to pandemics in collaboration with global health organisations such as WHO and the Pasteur Network.
Innovations in Progress
Research on novel antibiotics derived from natural compounds.
A global database of AMR genes to track resistance patterns.
Trials of next-generation mRNA vaccines for respiratory and vector-borne diseases.
Pasteur-UK Projects
Drug Discovery
Diagnostics and Surveillance
Pillar 3: Origins of Disease
Understanding the Roots of Human Health and Illness
Why do certain individuals develop chronic diseases, while others remain resilient? How do environmental, genetic, and microbial factors intersect to drive the onset of conditions like diabetes, cancer, or inflammatory disorders? The Institut Pasteur is uncovering the answers to these questions by studying the complex mechanisms that underlie human health.
Key Focus Areas
CHRONIC INFLAMMATORY DISORDERS
Investigating the rise of autoimmune diseases and how inflammation contributes to cancer, cardiovascular disease, and more.
THE MICROBIOME'S ROLE
Exploring how the trillions of microbes that live in and on our bodies influence disease development, immune function, and mental health.
HOST_PATHOGEN INTERACTIONS
Studying how genetic and environmental factors shape individual responses to infections, contributing to long-term outcomes.
UNDERSTANDING DIVERSITY
Understanding neurodevelopmental conditions and the support needs required following diagnosis.
Innovations in Progress
Cutting-edge studies into the microbiome's role in regulating immunity and metabolism.
Advanced imaging to track cellular changes during disease onset.
AI-driven analysis of genetic data to identify markers for disease predisposition.
Pasteur-UK Projects
Neurodevelopmental Diversity and Mental Health
Pillar 4: Health and Disease at the Extremes of Life
Protecting the Most Vulnerable
The earliest and latest stages of life are uniquely vulnerable to health challenges. From maternal and child health to aging populations, the Institut Pasteur is committed to advancing science that supports well-being throughout the lifespan.
Key Focus Areas
MATERNAL-CHILD HEALTH
Studying the role of the maternal microbiome during pregnancy and its influence on child development, immunity, and lifelong health.
VACCINATION ACROSS LIFESPANS
Developing vaccines tailored for newborns and the elderly, two groups with distinct immune needs.
AGEING AND IMMUNITY
Understanding how the immune system changes with age and identifying interventions to reduce susceptibility to infections and chronic diseases.
NEURODEGENERATIVE DISEASE
Using novel approaches to better diagnose neurodegenerative diseases early on.
Innovations in Progress
Investigations into the long-term effects of maternal nutrition on child microbiome composition.
Clinical trials for vaccines that are more effective in seniors, focusing on flu, pneumonia and RSV.
Studies on how ageing impacts the efficacy of immunotherapies for cancer.
Pasteur-UK Projects
Neurodegenerative Diseases and AI